ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,079Hybrid

Drug Testing and Analysis

Acronym:dta
•
Abbreviation (ISO):Drug Test. Anal
•
Identifier (ISSN):1942-7603(Print)/1942-7611(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
2.6↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drug Testing and Analysis

WoS Q3
12452.9920182.820192.920203.3520213.2320222.920232.620242.720252.62026
Annual Impact Factor Metric
Current (2026):2.6
Scopus SJR & RankScopus Q2
0.712
#8,079

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
74

74 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate26.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
175articles/year
43.78% Gold OA•94.71% Original Research

Aims & Scope

As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances. In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds). Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.

Topics Covered (Recognized by AI)
Medicine81.2%Biology79.2%Chemistry78.7%Biochemistry60.1%Internal medicine58.8%Chromatography51.1%Endocrinology43.8%Pharmacology41.7%Physics41.7%Organic chemistry41.3%Genetics38.3%Psychology35.2%Quantum mechanics31.6%Psychiatry30.8%Mass spectrometry25.7%Urine22.2%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMICAL RESEARCH METHODS

Q3
Rank47/85
IndexSCIE
JCRSCIE2026

CHEMISTRY, ANALYTICAL

Q3
Rank64/110
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank195/356
IndexSCIE
JCISCIE2026

BIOCHEMICAL RESEARCH METHODS

Q2
Rank39/85
IndexSCIE
JCISCIE2026

CHEMISTRY, ANALYTICAL

Q2
Rank47/110
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank157/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.6
Articles / Year136
Total Citations41
2025
IF2.7
Articles / Year170
Total Citations380
2024
IF2.6
Articles / Year227
Total Citations1,036
2023
IF2.9
Articles / Year204
Total Citations1,442
2022
IF3.234
Articles / Year218
Total Citations2,303

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,079Scopus Q2SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:ChemistryEnvironmental SciencePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.712

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.98

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,157 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,447
3-Year Documents485
Citable Documents461

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)6

Citations in government and international policy documents

Female Author Rate43.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Analytical ChemistryQ2
Environmental ChemistryQ2
Pharmaceutical ScienceQ2
SpectroscopyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 26.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区BIOCHEMICAL RESEARCH METHODS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Testing and Analysis (acronym: dta, abbr: Drug Test. Anal, ISSN: 1942-7603) is a peer-reviewed international scholarly journal in the field of BIOCHEMICAL RESEARCH METHODS, published by John Wiley and Sons Ltd in England since 2009. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.712 (Q2), an H-index of 74.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 175 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,157 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
2009
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 83ba45a5-3823-4d4a-bb22-f40fc1229c60
Database Updated: 2026-09-29